Page last updated: 2024-08-24

tenofovir and Kaposi Sarcoma

tenofovir has been researched along with Kaposi Sarcoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Kerkemeyer, KLS; Lai, FYX; Mar, A1
Lodi, VJC; Monteiro, JCMS; Pires, CAA; Rego, RM1
Cardoso, SV; de Faria, PR; Loyola, AM; Servato, JP; Spini, PH; Spini, TH1
Chima-Okereke, C; Sivaprakasam, V1
Corona, G; Innocenti, F; Sandron, S; Sartor, I; Tirelli, U; Toffoli, G; Vaccher, E1

Other Studies

5 other study(ies) available for tenofovir and Kaposi Sarcoma

ArticleYear
Kaposi's Sarcoma Occurring in HIV Infection Controlled on HAART.
    The American journal of medicine, 2020, Volume: 133, Issue:6

    Topics: Ankle; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Emtricitabine; Foot; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lymphedema; Male; Middle Aged; Oxazines; Piperazines; Pyridones; Sarcoma, Kaposi; Skin Neoplasms; Sustained Virologic Response; Tenofovir; Viral Load

2020
Kaposi's sarcoma in a HIV-positive patient: an exuberant and widespread case report in the Amazon.
    Revista do Instituto de Medicina Tropical de Sao Paulo, 2020, Volume: 62

    Topics: Adult; Anti-HIV Agents; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Male; Oxazines; Piperazines; Pyridones; Sarcoma, Kaposi; Skin Neoplasms; Tenofovir

2020
Regression of oral Kaposi's sarcoma after combination antiretroviral therapy.
    Infection, 2013, Volume: 41, Issue:6

    Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Humans; Lamivudine; Male; Organophosphonates; Sarcoma, Kaposi; Tenofovir

2013
An interesting case of 'diabetic foot ulcer' in an HIV-positive patient.
    International journal of STD & AIDS, 2015, Volume: 26, Issue:4

    Topics: Adenine; Aged; Antiretroviral Therapy, Highly Active; Biopsy; Deoxycytidine; Diabetes Mellitus, Type 2; Diabetic Foot; Emtricitabine; Herpesvirus 8, Human; HIV Infections; HIV Seropositivity; Humans; Male; Organophosphonates; Sarcoma, Kaposi; Skin Neoplasms; Tenofovir; Treatment Outcome; Ulcer

2015
Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Adenine; Adult; Aged; Anti-HIV Agents; Antineoplastic Agents, Phytogenic; Antiretroviral Therapy, Highly Active; Area Under Curve; Camptothecin; Drug Therapy, Combination; HIV Infections; Humans; Irinotecan; Lamivudine; Lopinavir; Male; Middle Aged; Organophosphonates; Pyrimidinones; Ritonavir; Sarcoma, Kaposi; Tenofovir; White People

2008